CVS Caremark PT Raised to $85.00 at Mizuho (CVS)
Analysts at Mizuho hoisted their price target on shares of CVS Caremark (NYSE:CVS) from $81.00 to $85.00 in a research report issued to clients and investors on Wednesday. The firm currently has a “buy” rating on the stock. Mizuho’s target price indicates a potential upside of 10.00% from the stock’s previous close.
CVS Caremark (NYSE:CVS) opened at 77.27 on Wednesday. CVS Caremark has a 1-year low of $56.32 and a 1-year high of $79.43. The stock has a 50-day moving average of $76.91 and a 200-day moving average of $74.23. The company has a market cap of $90.638 billion and a P/E ratio of 19.70. CVS Caremark also was the recipient of some unusual options trading activity on Monday. Stock traders bought 7,359 put options on the stock. This represents an increase of 776% compared to the typical daily volume of 840 put options.
CVS Caremark (NYSE:CVS) last announced its earnings results on Tuesday, August 5th. The company reported $1.13 earnings per share for the quarter, beating the analysts’ consensus estimate of $1.10 by $0.03. The company had revenue of $34.60 billion for the quarter, compared to the consensus estimate of $33.47 billion. During the same quarter last year, the company posted $0.97 earnings per share. CVS Caremark’s revenue was up 10.7% compared to the same quarter last year. Analysts expect that CVS Caremark will post $4.46 EPS for the current fiscal year.
CVS has been the subject of a number of other recent research reports. Analysts at Cowen and Company raised their price target on shares of CVS Caremark from $80.00 to $85.00 in a research note on Wednesday. Separately, analysts at ISI Group raised their price target on shares of CVS Caremark from $86.00 to $88.00 in a research note on Tuesday. They now have a “strong-buy” rating on the stock. Finally, analysts at ISI Group downgraded shares of CVS Caremark to an “underperform” rating in a research note on Tuesday. They now have a $54.00 price target on the stock, down previously from $86.00. One research analyst has rated the stock with a sell rating, four have issued a hold rating, twelve have given a buy rating and one has given a strong buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus target price of $78.62.
CVS Caremark Corporation (NYSE:CVS), together with its subsidiaries, is a pharmacy health care provider in the United States.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.